|
|
| (11) | Number of the document | C 2404919 |
| (68) | Number of the document | 2404919 |
| (21) | Application number for Supplementary Protection Certificate | PA 2016 015 |
| (22) | Date of filing the application | 2016-05-13 |
| (41) | Date of publication of the application | 2016-06-10 |
| Date of publication of SPC | 2017-12-27 | |
| (24) | Date of coming into effect of SPC | 2026-11-09 |
| (71) |
Vertex Pharmaceuticals Inc.,
50 Northern Avenue, Boston, MA 02210,
US
|
| (73) |
Vertex Pharmaceuticals Inc.,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/15/1059, 2015-11-19 |
| (94) | 2030-11-24 |
| (95) | 3-{6-{[1-(2,2-Difluor-1,3-benzodioksol-5-il)ciklopropankarbonil]amino}-3-metilpiridin-2-il}benzoinė rūgštis arba jos farmaciniu požiūriu priimtina druska arba esteris |
| SPC granted |